Winton Group LTD Aclaris Therapeutics, Inc. Transaction History

Winton Group LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$2.65 - $7.61 $126,031 - $361,923	-47,559 Closed	0 $0
Q3 2020 Oct 30, 2020	BUY	$1.5 - $2.71 $3,573 - $6,455	2,382 Added 5.27%	47,559 $122,000
Q2 2020 Aug 05, 2020	SELL	$1.04 - $1.73 $73,488 - $122,245	-70,662 Reduced 61.0%	45,177 $73,000
Q1 2020 May 11, 2020	SELL	$0.75 - $2.18 $64,483 - $187,432	-85,978 Reduced 42.6%	115,839 $120,000
Q4 2019 Feb 13, 2020	SELL	$1.02 - $1.97 $8,812 - $17,020	-8,640 Reduced 4.11%	201,817 $381,000
Q3 2019 Nov 08, 2019	BUY	$0.79 - $2.47 $166,261 - $519,828	210,457 New	210,457 $227,000

50.7M

30.6K

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $271M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

Stay updated on Winton Group LTD with notifications on news.